Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT01658410

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01658410
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01658410. Randomized; triple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG
Condition
Aorto-coronary Bypass Grafting
Intervention (Drug)
BQ-123
Intervention (Drug)
NaCl
Lead sponsor
Medical University of Vienna (class: other)

Record details

Record id
cardio:ct-nct01658410
Content hash
cf77dddc61272a4fa19d2de5758e5ee834762e4f474bde509389964968b042b2